Pediatric Nephrology

, Volume 27, Issue 4, pp 551–561 | Cite as

Surgical management of vesicoureteral reflux in children

  • Jennifer Sung
  • Steven Skoog
Educational Review


Vesicoureteral reflux (VUR) is the most common uropathy affecting children. Compared to children without VUR, those with VUR have a higher rate of pyelonephritis and renal scarring following urinary tract infection (UTI). Options for treatment include observation with or without antibiotic prophylaxis and surgical repair. Surgical intervention may be necessary in patients with persistent reflux, renal scarring, and recurrent or breakthrough febrile UTI. Both open and endoscopic approaches to reflux correction are successful and reduce the occurrence of febrile UTI. Estimated success rates of open and endoscopic reflux correction are 98.1% (95% CI 95.1, 99.1) and 83.0% (95% CI 69.1, 91.4), respectively. Factors that affect the success of endoscopic injection include pre-operative reflux grade and presence of functional or anatomic bladder abnormalities including voiding dysfunction and duplicated collecting systems. Few studies have evaluated the long-term outcomes of endoscopic injection, and with variable results. In patients treated endoscopically, recurrent febrile UTI occurred in 0–21%, new renal damage in 9–12%, and recurrent reflux in 17–47.6% of treated ureters with at least 1 year follow-up. These studies highlight the need for standardized outcome reporting and longer follow-up after endoscopic treatment.


Vesicoureteral reflux Endoscopy Surgery Laparoscopy Uropathy 



Vesicoureteral reflux


Dextranomer/hyaluronic acid


Urinary tract infection


Urogenital sinus


Ureterovesical junction


Voiding cystourethrography


Radionuclide cystogram




Subureteric Teflon injection


Hydrodistention implantation technique


99mTechnetium-dimercaptosuccinic acid


American Urological Association


Continuous antibiotic prophylaxis



  1. 1.
    Bailey RR (1979) Vesicoureteral reflux in healthy infants and children. Reflux Nephropathy 59–61Google Scholar
  2. 2.
    Sargent MA (2000) What is the normal prevalence of vesicoureteral reflux? Pediatr Radiol 30:587–593PubMedCrossRefGoogle Scholar
  3. 3.
    Skoog SJ, Peters CA, Arant BS Jr, Copp HL, Elder JS, Hudson RG, Khoury AE, Lorenzo AJ, Pohl HG, Shapiro E, Snodgrass WT, Diaz M (2010) Pediatric vesicoureteral reflux guideline panel summary report: clinical practice guidelines for screening siblings of children with vesicoureteral reflux and neonates/infants with prenatal hydronephrosis. J Urol 184(3):1145–1151PubMedCrossRefGoogle Scholar
  4. 4.
    Zerin JM, Ritchey ML, Chang AC (1993) Incidental vesicoureteral reflux in neonates with antenatally detected hydronephrosis and other renal abnormalities. Radiol 187:157–160Google Scholar
  5. 5.
    Viana R, Batourina E, Huang H, Dressler GR, Kobayashi A, Behringer RR, Shapiro E, Hensle T, Lambert S, Mendelsohn C (2007) The development of the bladder trigone, the center of the anti-reflux mechanism. Development 134(20):3763–3769PubMedCrossRefGoogle Scholar
  6. 6.
    Mackie GG, Awang H, Stephens FD (1975) The ureteric orifice: the embryologic key to radiologic status of duplex kidneys. J Pediatr Surg 10:473–481PubMedCrossRefGoogle Scholar
  7. 7.
    Mackie GG, Stephens FD (1975) Duplex kidneys: a correlation of renal dysplasia with position of the ureteral orifice. J Urol 114:274–280PubMedGoogle Scholar
  8. 8.
    Paquin AJ (1959) Ureterovesical anastomosis: the description and evaluation of a technique. J Urol 82:573–583PubMedGoogle Scholar
  9. 9.
    Peters CA, Skoog SJ, Arant BS, Copp HL, Elder JS, Hudson RG, Khoury AE, Lorenzo AJ, Pohl HG, Shapiro E, Snodgrass WT, Diaz M (2010) Summary of the AUA guideline on management of primary vesicoureteral reflux in children. J Urol 184(3):1134–1144PubMedCrossRefGoogle Scholar
  10. 10.
    Duckett JW, Bellinger M (1982) A plea for standardized grading of vesicoureteral reflux. Eur Urol 8:74–77PubMedGoogle Scholar
  11. 11.
    International Reflux Study Committee (1981) Medical versus surgical treatment of primary vesicoureteral reflux: report of the International Reflux Study Committee. Pediatrics 67:392–400Google Scholar
  12. 12.
    Knudson MJ, Austin JC, McMillan ZM, Hawtrey CE, Cooper CS (2007) Predictive factors of early spontaneous resolution in children with primary vesicoureteral reflux. J Urol 178:1684–1688PubMedCrossRefGoogle Scholar
  13. 13.
    Skoog SJ, Belman AB, Majd M (1987) A nonsurgical approach to the management of primary vesicoureteral reflux. J Urol 138:941–946PubMedGoogle Scholar
  14. 14.
    Austin JC, Cooper CS (2010) Vesicoureteral reflux: who benefits from correction. Urol Clin N Am 37:243–252CrossRefGoogle Scholar
  15. 15.
    Shaikh N, Ewing AL, Bhatnagar S, Hoberman A (2010) Risk of renal scarring in children with a first urinary tract infection: a systematic review. Pediatrics 126(6):1–8CrossRefGoogle Scholar
  16. 16.
    Elder JS, Peters CA, Arant BS, Ewalt DH, Hawtrey CE, Hurwitz RS, Parrott TS, Snyder HM, Weiss RA, Woolf SH, Hasselblad V (1997) Pediatric vesicoureteral reflux guidelines panel summary report on the management of primary vesicoureteral reflux in children. J Urol 157:1846–1851PubMedCrossRefGoogle Scholar
  17. 17.
    Children’s Hospital Boston (2011) VUR Resolution Rate Calculator,
  18. 18.
    Jodal U, Smellie JM, Lax H, Hoyer PF (2006) Ten-year results of randomized treatment of children with severe vesicoureteral reflux. Final report of the International Reflux Study in Children. Pediatr Nephrol 21:785–792PubMedCrossRefGoogle Scholar
  19. 19.
    Olbing H, Smellie JM, Jodal U, Lax H (2003) New renal scars in children with severe VUR: a 10-year study of randomized treatment. Pediatr Nephrol 18:1128–1131PubMedCrossRefGoogle Scholar
  20. 20.
    Birmingham Reflux Study Group (1987) Prospective trial of operative versus non-operative treatment of severe vesicoureteric reflux in children: five years’ observation. Birmingham Reflux Study Group. Br Med J 295:237–241CrossRefGoogle Scholar
  21. 21.
    Hutch JA (1952) Vesicoureteral reflux in the paraplegic: cause and correction. J Urol 68:457–469PubMedGoogle Scholar
  22. 22.
    Lich R Jr (1961) Recurrent urosepsis in children. J Urol 86:554–558Google Scholar
  23. 23.
    Gregoir W, Van Regemorter G (1964) Le reflux vesico-ureteral congenital. Urol Int 18:122–136PubMedCrossRefGoogle Scholar
  24. 24.
    Riedmiller H, Gerharz EW (2008) Antireflux surgery: Lich-Gregoir extravesical ureteric tunneling. BJUI 101:1467–1482CrossRefGoogle Scholar
  25. 25.
    Politano VA, Leadbetter WF (1958) An operative technique for the correction of vesicoureteral reflux. J Urol 79:932–941PubMedGoogle Scholar
  26. 26.
    Steffens J, Stark E, Haben B, Treiyer A (2006) Politano-Leadbetter ureteric reimplantation. BJUI 98:695–712CrossRefGoogle Scholar
  27. 27.
    Glenn JF, Anderson EE (1967) Distal tunnel ureteral reimplantation. J Urol 97:623–626PubMedGoogle Scholar
  28. 28.
    Glenn JF, Anderson EE (1978) Technical considerations in distant tunnel ureteral reimplantation. J Urol 119:194–198PubMedGoogle Scholar
  29. 29.
    Cohen SJ (1975) Uretozystoneostomie: eine neue antireflux Technik. Aktuelle Urol 6:1Google Scholar
  30. 30.
    Retik AB, Colodny AH, Bauer SB (1984) Genitourinary surgery: pediatric urology, vol 2. Churchill Livingston, NY, p 764Google Scholar
  31. 31.
    Ehrlich RM, Gershman A, Fuchs G (1994) Laparoscopic vesicoureteroplasty in children: initial case reports. Urol 433:255–261CrossRefGoogle Scholar
  32. 32.
    Janetschek G, Radmayr C, Bartsch G (1995) Laparoscopic ureteral anti-reflux plasty reimplantation. First clinical experience. Ann Urol 29:101–105Google Scholar
  33. 33.
    Hayn MH, Smaldone MC, Ost MC, Docimo SG (2008) Minimally invasive treatment of vesicoureteral reflux. Urol Clin N Am 35:477–488CrossRefGoogle Scholar
  34. 34.
    Läckgren G, Kirsch AJ (2010) Endoscopic treatment of vesicoureteral reflux. BJUI 9(105):1332–1447CrossRefGoogle Scholar
  35. 35.
    O’Donnell B, Puri P (1984) Treatment of vesicoureteric reflux by endoscopic injection of Teflon. Br Med J 289:7–9CrossRefGoogle Scholar
  36. 36.
    Puri P, Pirker M, Mohanan N, Dawrant M, Dass L, Colhoun E (2006) Subureteral dextranomer/hyaluronic acid injection as first line treatment in the management of high grade vesicoureteral reflux. J Urol 176:1856–1860PubMedCrossRefGoogle Scholar
  37. 37.
    Kirsch AJ, Perez-Brayfield M, Smith EA, Scherz HC (2004) The modified STING procedure to correct vesicoureteral reflux: improved results with submucosal implantation within the intramural ureter. J Urol 171:2413–2416PubMedCrossRefGoogle Scholar
  38. 38.
    McMann LP, Scherz HC, Kirsch AJ (2007) Long-term preservation of dextranomer/hyaluronic acid copolymer implants after endoscopic treatment of vesicoureteral reflux in children: a sonographic volumetric analysis. J Urol 166:316–320CrossRefGoogle Scholar
  39. 39.
    Routh JC, Reinberg Y, Ashley RA, Inman BA, Wolpert JJ, Vandersteen DR, Husmann DA, Kramer SA (2007) Multivariate comparison of the efficacy of intraureteral versus subtrigonal techniques of dextranomer/hyaluronic acid injection. J Urol 178:1702–1706PubMedCrossRefGoogle Scholar
  40. 40.
    Yucel S, Gupta A, Snodgrass W (2007) Multivariate analysis of factors predicting success with dextranomer/hyaluronic acid injection for vesicoureteral reflux. J Urol 177(4):1505–1509PubMedCrossRefGoogle Scholar
  41. 41.
    Gupta A, Snodgrass W (2008) Intra-orifice versus hydrodistention implantation technique in dextranomer/hyaluronic acid injection for vesicoureteral reflux. J Urol 180:1589–1593PubMedCrossRefGoogle Scholar
  42. 42.
    Lavelle MT, Conlin MJ, Skoog SJ (2004) Subureteral injection of deflux for correction of reflux: analysis of factors predicting success. J Urol 65:564–567Google Scholar
  43. 43.
    Routh JC, Reinberg Y (2010) Predicting success in the endoscopic management of pediatric vesicoureteral reflux. Urol 76(1):195–198PubMedCrossRefGoogle Scholar
  44. 44.
    Elder JS, Diaz M, Caldamone AA, Cendron M, Greenfield S, Hurwitz R, Kirsch A, Koyle MA, Pope J, Shapiro E (2006) Endoscopic therapy for vesicoureteral reflux: a meta-analysis. I. Reflux resolution and urinary tract infection. J Urol 175:716–722PubMedCrossRefGoogle Scholar
  45. 45.
    Routh JC, Inman BA, Reinberg Y (2010) Dextranomer/Hyaluronic acid for pediatric vesicoureteral reflux: systematic review. Pediatrics 125(5):1010–1019PubMedCrossRefGoogle Scholar
  46. 46.
    Holmdahl G, Brandström P, Läckgren G, Sillén U, Stokland E, Jodal U, Hansson S (2010) The Swedish reflux trial in children: II. Vesicoureteral reflux outcome. J Urol 184:280–285PubMedCrossRefGoogle Scholar
  47. 47.
    Läckgren G, Wåhlin N, Sköldenberg E, Stenberg A (2001) Long-term followup of children treated with dextranomer/hyaluronic acid copolymer for vesicoureteral reflux. J Urol 166:1887–1892PubMedCrossRefGoogle Scholar
  48. 48.
    Oswald J, Riccabona M, Lusuardi L, Bartsch G, Radmayr C (2002) Prospective comparison and 1-year follow-up of a single endoscopic subureteral polydimethylsiloxane versus dextranomer/hyaluronic acid copolymer injection for treatment of vesicoureteral reflux in children. Urol 60(5):894–897PubMedCrossRefGoogle Scholar
  49. 49.
    Lee EK, Gatti JM, Demarco RT, Murphy JP (2009) Long-term followup of dextranomer/hyaluronic acid injection for vesicoureteral reflux: late failure warrants continued followup. J Urol 181:1869–1875PubMedCrossRefGoogle Scholar
  50. 50.
    Hsieh MH, Madden-Fuentes RJ, Lindsay NE, Roth DR (2010) Treatment of pediatric vesicoureteral reflux using endoscopic injection of hyaluronic acid/dextranomer gel: intermediate-term experience by a single surgeon. Urol 76(1):199–203PubMedCrossRefGoogle Scholar
  51. 51.
    Brandström P, Esbjörner E, Herthelius M, Swerkersson S, Jodal U, Hansson S (2010) The Swedish reflux trial in children: III. Urinary tract infection pattern. J Urol 184:286–291PubMedCrossRefGoogle Scholar
  52. 52.
    Weiss R, Duckett J, Spitzer A (1992) Results of a randomized clinical trial of medical versus surgical management of infants and children with grades III and IV primary vesicoureteral reflux (United States). J Urol 148:1667PubMedGoogle Scholar
  53. 53.
    Brandström P, Nevéus T, Sixt R, Stokland E, Jodal U, Hansson S (2010) The Swedish reflux trial in children: IV. Renal damage. J Urol 184:292–297PubMedCrossRefGoogle Scholar
  54. 54.
    Chertin B, Natsheh A, Fridmans A, Shenfeld OZ, Farkas A (2009) Renal scarring and urinary tract infection after successful endoscopic correction of vesicoureteral reflux. J Urol 182:1703–1707PubMedCrossRefGoogle Scholar
  55. 55.
    Benoit RM, Peele PB, Docimo SG (2006) The cost-effectiveness of dextranomer/hyaluronic acid copolymer for the management of vesicoureteral reflux: 1: substitution for surgical management. J Urol 176:1588–1592PubMedCrossRefGoogle Scholar
  56. 56.
    Kobelt G, Canning DA, Hensle TW, Lackgren G (2003) The cost-effectiveness of endoscopic injection of dextranomer/hyaluronic acid copolymer for vesicoureteral reflux. J Urol 169:1480–1485PubMedCrossRefGoogle Scholar
  57. 57.
    Hensle TW, Grogg AL, Eaddy M (2007) Pediatric vesicoureteral reflux: treatment patterns and outcomes. Nat Clin Prac Urol 4(9):462–463CrossRefGoogle Scholar
  58. 58.
    Hsieh MH, Madden-Fuentes RJ, Bayne A, Munch E, Wildenfels P, Alexander SJ, Gonzales ET Jr, Cisek LJ, Jones EA, Roth DR (2010) Cross-sectional evaluation of parental decision making factors for vesicoureteral reflux management in children. J Urol 184:1589–1593PubMedCrossRefGoogle Scholar
  59. 59.
    Routh JC, Nelson CP, Graham DA, Lieu TA (2010) Variation in surgical management of vesicoureteral reflux: influence of hospital and patient factors. Pediatrics 125(3):446–451CrossRefGoogle Scholar
  60. 60.
    Kirsch AJ, Perez-Brayfield MR, Scherz HC (2003) Minimally invasive treatment of vesicoureteral reflux with endoscopic injection of dextranomer/hyaluronic acid copolymer: the Children’s Hospitals of Atlanta experience. J Urol 170:211–215PubMedCrossRefGoogle Scholar

Copyright information

© IPNA 2011

Authors and Affiliations

  1. 1.SurgeryOHSUPortlandUSA

Personalised recommendations